USA - engelsk - NLM (National Library of Medicine)

synthon pharmaceuticals, inc. - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288) - tablet - 2.5 mg - amlodipine besylate is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. amlodipine besylate is indicated for the treatment of chronic stable angina. amlodipine besylate may be used alone or in combination with other antianginal agents. amlodipine besylate is indicated for the treatment of confirmed or suspected vasospastic angina. amlodipine besylate may be used as monotherapy or in combination with other antianginal drugs. amlodipine besylate is contraindicated in patients with known sensitivity to amlodipine.

USA - engelsk - NLM (National Library of Medicine)

synthon pharmaceuticals, inc. - zolpidem tartrate (unii: wy6w63843k) (zolpidem - unii:7k383oqi23) - tablet, film coated - 5 mg - zolpidem tartrate tablets are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. zolpidem tartrate tablets have been shown to decrease sleep latency for up to 35 days in controlled clinical studies [see clinical studies (14)] . the clinical trials performed in support of efficacy were 4-5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment. zolpidem tartrate tablets are contraindicated in patients with known hypersensitivity to zolpidem tartrate or to any of the inactive ingredients in the formulation. teratogenic effects: pregnancy category c zolpidem tartrate was administered to pregnant sprague-dawley rats by oral gavage during the period of organogenesis at doses of 4, 20, or 100 mg based/kg/day. adverse maternal and embryo/fetal effects occurred at doses of 20 mg base/kg and higher, manifesting as dose-related lethargy and ataxia in pregnant rats while examination of fetal skull bones revealed a dose

Latvia - latvisk - Zāļu valsts aģentūra

synthon bv, netherlands - ibandronskābe - apvalkotā tablete - 150 mg

Ungarn - ungarsk - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

synthon bv - levocetirizine -

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

synthon b.v. nijmegen, the netherlands - letrozole - ΕΠΙΚΑΛΥΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - 2,5mg/tab - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

synthon b.v. nijmegen, the netherlands - valsartan - ΕΠΙΚΑΛΥΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - 40mg/tab - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

synthon b.v. nijmegen, the netherlands - valsartan - ΕΠΙΚΑΛΥΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - 80mg/tab - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

synthon b.v. nijmegen, the netherlands - valsartan - ΕΠΙΚΑΛΥΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - 320mg/tab - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

synthon b.v., the netherlands - anastrozole - ΕΠΙΚΑΛΥΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - 1mg/tab - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

synthon b.v. nijmegen, the netherlands (0000005989) microweg 22, 6545 cm nijmegen - exemestane - ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - 25mg/tab - ineof01270 exemestane 25.000000 mg - exemestane